Back
H. Lundbeck AS Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
46
HLUBF
H. Lundbeck AS
Last Price:
5.25
Seasonality Move:
3.47%
Sell
32
ASND
Ascendis Pharma AS
Last Price:
130.69
Seasonality Move:
25.97%
Sell
46
H. Lundbeck AS (HLUBF)
is a Sell
Is H. Lundbeck AS a Buy, Sell or Hold?
- The current H. Lundbeck AS [HLUBF] share price is $5.25. The Score for HLUBF is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- HLUBF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $134.28. The Score for ASND is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HLUBF Stock Price Chart
What is H. Lundbeck AS's stock price today?
-
The H. Lundbeck AS share price today is $5.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HLUBF is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $134.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.
HLUBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 28.16 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.2 - 5.44) | Sell |
| Bollinger Bands (100): | (5.16 - 5.96) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.08 | Buy |
| Relative Strength Index (14 RSI): | 56.76 | Buy |
| Chaikin Money Flow: | 226132 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (125.12 - 133.42) | Buy |
| Bollinger Bands (100): | (123.93 - 140.87) | Buy |
HLUBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.23 | Buy |
| 20-day SMA: | 5.29 | Sell |
| 50-day SMA: | 5.44 | Sell |
| 200-day SMA: | 4.86 | Buy |
| 8-day EMA: | 5.24 | Buy |
| 20-day EMA: | 5.29 | Sell |
| 50-day EMA: | 5.41 | Sell |
| 200-day EMA: | 5.07 | Buy |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 132.16 | Buy |
| 20-day SMA: | 129.76 | Buy |
| 50-day SMA: | 130.2 | Buy |
| 200-day SMA: | 135.71 | Sell |
| 8-day EMA: | 132.17 | Buy |
| 20-day EMA: | 130.88 | Buy |
| 50-day EMA: | 130.81 | Buy |
| 200-day EMA: | 130.54 | Buy |
H. Lundbeck AS Earnings Growth & HLUBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $4.01 per share.
H. Lundbeck AS Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||